Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
ConditionInterstitial Lung Disease (ILD)
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorRegion Skane
About this trial
The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).
Eligibility criteria
Qualifiers
The subject has given written consent to participate in the study
Physician diagnosis of fibrosing ILD according to international guidelines
age 18 years or older
able to cycle
Disqualifiers
Resting peripheral oxygen saturation (SpO2) < 92%
hospitalization or clinical instability during the last four weeks
treatment with supplementary oxygen at rest or during exercise
contraindication to exercise testing in accordance with clinical practice guidelines
Trial design
Treatments tested in this trial
- L-menthol
- Placebo
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Region Skane
Lead sponsor
Blekinge Institute of Technology
Collaborator
Blekingesjukhuset, Karlskrona
Collaborator
Lund University
Collaborator
Source ClinicalTrials.gov